Caring for patients through trusted partnerships, expanding healthcare and improving lives.
Bora Health has established a strong presence in Taiwan’s central nervous system (CNS) therapeutic market—one of the top three prescription drug sectors—offering not only its own branded products but also distributing CNS medicines for multiple international pharmaceutical companies.
Building on its solid foundation in the CNS market, Bora Health is actively expanding its portfolio into various specialty areas, including neurology, nephrology, cardiology, infectious diseases, and rare diseases, aiming to deliver comprehensive solutions that benefit a broader patient population.
With extensive local expertise in pharmaceutical marketing and a highly professional sales team well-versed in multi-country regulations and drug compliance standards, Bora Health provides international partners with end-to-end partnership services, including market strategy analysis and opportunity assessment, regulatory submissions and approval processes, NHI pricing negotiations, hospital formulary entry and distribution planning, clinic and pharmacy expansion support, customized brand promotion campaigns, distribution execution, and sales advancement.
Through its well-established network of hospitals, clinics, pharmacies, and retail channels, Bora Health enables international partners to effectively enter and expand in the Taiwan market, achieving sustainable sales growth while significantly enhancing brand visibility and market share.
In response to the global aging population, Bora Health strengthens its presence in the CNS (central nervous system) product sector through strategic partnerships and the distribution of niche products. Its portfolio includes BRINTELLIX, the latest antidepressant from Denmark’s leading CNS pharmaceutical company, Lundbeck.
In June 2019, Bora Health obtained regulatory approval from Taiwan’s Ministry of Health and Welfare for Numient’s Rytary (extended-release) capsules, primarily used to treat Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonian syndromes.
Furthermore, in 2022, Bora Health signed distribution agreements for Rytary in China, Hong Kong, and Macau, expanding its sales reach overseas.
Const-K, manufactured by Bora E-Born Plant, is a product for which Bora holds the global marketing authorization. Bora Health is responsible for its global distribution, and the product has already been introduced to all hospital channels in Taiwan. This sustained-release formulation significantly reduces gastrointestinal discomfort, enabling patients with hypokalemia to steadily restore their blood potassium levels to a normal range.
In addition to CNS products, the current portfolio of prescription medicines also includes products used in various therapeutic areas such as infectious diseases, nephrology, ophthalmology, cardiovascular diseases, rheumatology and immunology, and gastroenterology. Bora Health is responsible for integrating and managing the group’s prescription drug marketing operations, with sales partners spanning across the globe, primarily in Asia.
While maintaining its focus on the central nervous system field, Bora Health is also expanding its product portfolio to address the needs arising from an aging population. By continuously introducing high-quality global pharmaceuticals, providing comprehensive patient education, and collaborating with patient support organizations, Bora Health aims to benefit more patients both domestically and internationally.
Bora Group has a professional sales team with extensive local marketing experience and a strong understanding of international regulations and pharmaceutical standards. We provide international partners with comprehensive, one-stop integrated services, covering :
Through a carefully established network of medical centers, clinics, pharmacies, and retail outlets, Bora Group not only helps partners quickly enter the Taiwan market but also effectively enhances sales performance and brand visibility while steadily expanding market share. Currently, our service offerings cover three main categories:
Get in touch to explore new possibilities. Our team is ready to connect with you.
